TD Cowen Initiates Coverage On Arcus Biosciences with Buy Rating

TD Cowen analyst Tara Bancroft has initiated coverage on Arcus Biosciences (NYSE: RCUS) with a Buy rating. This marks a positive outlook for the company in the market.